The monomethyl ester 2MeOdipicH (1) of 2,5-dipicolinic acid, characterized as its magnesium salt [Mg(H 2 O) 6 ]-(2MeOdipic) 2 , was converted, via the diesters 2MeO-5ROdipic and the copper complexes [Cu (5ROdipic) 
Introduction
During the last two decades, in vitro and in vivo studies have demonstrated the potential of many vanadium compounds as insulin-mimetic (or insulin-enhancing) agents. [1] [2] [3] Among those which have been shown to be effective are bis(maltolato)oxidovanadium complexes, [4a] which successfully passed clinical tests phase I, [4b] [VO-(pic) 2 ] which normalizes serum glucose and fatty acid levels in rats with streptozotozin-induced diabetes type 1, [5] and [VO 2 (H 2 O)(2,6-dipic)] -, which had beneficial effects in cats suffering from diabetes type 2. [6] Picolinato complexes of vanadium appear to be generally effective, [7] the extent, however, to which they actually mimic the involvement of insulin in the glucose and lipid metabolisms is subject to variations in the coordination periphery. We 2 O were characterized by single-crystal X-ray diffraction analysis. Selected type 4 and 5 complexes were submitted to in vitro tests (fibroblasts, SV 3T3 mice fibroblasts) for their uptake kinetics and insulin-mimetic behavior. The compounds were comparable to insulin in their ability to stimulate cellular glucose uptake and metabolism. In vitro tests with rat adipocytes showed that the complexes also mimic the ability of insulin to inhibit lipolysis.
(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006) of 2,5-dipicolinate, is clearly more effective than the corresponding ethyl ester both in the ability to trigger cellular glucose uptake (and metabolism) and to inhibit lipolysis. [8] These differences in impact correlate with the net amount of vanadium taken up by the cells, possibly indicative for a balanced hydro/lipophilicity being a key factor in efficacy.
An apparent advantage of vanadium complexes in the treatment of diabetes mellitus type 1 (lacking insulin production) and type 2 (tolerance/resistance against insulin) is their application per os, and the possibility to design the compounds so as to provide minimal toxicity and optimal efficiency along with stability against redox-and hydrolytic break-down. The compound has to survive the acidic conditions pertinent to the stomach (pH typically around 2), as well as the slightly alkaline conditions in the small intestines (pH [7] [8] and the blood stream (pH 7.35). It has to resist to a certain extent competing ligands such as the plasma constituents citrate, phosphate and transferrin in order to preserve the information implanted by the specific properties of the ligands used in the synthesis of the potential drug. The complex should be easily absorbed in the gastrointestinal tract, transported by the blood stream at least partly intact, and traffic across the cell membrane. Oxidovanadium complexes carrying monoesters of 2,5-dipicolinic acid as ligands have been shown to fulfil several of these conditions. [8] Picolinates are natural metabolites; toxicity by degradation of the complexes thus will be minimized. In order to improve the trans-membrane transport, a fine-tuning of the hydro/lipophilicity by choosing the "correct" sub- Scheme 1. stituents in the ligand periphery is one option. A second option is to attach groups to the periphery for which membrane receptors exist and which can thus be recognized by the cell. Following these concepts, we have extended earlier investigations on picolinates to galactose and inositol derivatives on the one hand, and carboxamides derived from amino acids on the other hand. Scheme 1 gives an overview of the types of compounds discussed in the present work. Along with the vanadium complexes and their in vitro insulin-mimetic properties, structural features of ligands and ligand precursors will be described.
Results and Discussion

Synthesis, Characterization and Structure Determination
The syntheses of the ligands 2a-b followed the route depicted in Scheme 2. 6-(Methoxycarbonyl)pyridine-3-carboxylic acid (1) was converted into the corresponding acyl chloride by reaction with thionyl chloride. Addition of a solution of the acid chloride in toluene to a solution of the alcohol ROH (R = iPr, (S)-sBu, in 1.4 fold excess) in pyridine yielded the mixed diesters 2MeO-5ROdipic, which were converted via the copper complexes [Cu(5ROdipic) 2 ] into the acids 5ROdipicH, 2a-b. For the structure of the anion of 1, 1H -1 , see below.
Single crystals of 2b were grown from aqueous acetone solution. 2b crystallizes in the monoclinic space group P2 1 . Bond lengths and angles are in the expected range ( Table 1) . The molecular structure and a picture showing the hydrogen-bonding network are displayed in Figure 1 . The molecules are linked through OH···N hydrogen bonds, comparable to the features exhibited by other members of this family of dipicolinic acid derivatives. [8] The proligands 2c-d were synthesized in analogy to the ligands 2a-b, with the modification that equimolar amounts of acyl chloride and alcohol were reacted. The deprotection step via the copper complexes was omitted. The cleavage of the methyl ester group occurred in situ under the conditions chosen for the synthesis of the vanadium complexes and concomitantly with the coordination of the carboxylate function to vanadium.
For the syntheses of the amino acid derivatives 3a-d, cf. Scheme 2, a solution of the acyl chloride in dichloromethane was treated with a solution containing the amino acid ethyl ester hydrochloride and triethylamine in CH 2 Cl 2 , Figure 1 . Top: XSHELL plot of 2b (50 % probability level). Bottom: Hydrogen bonding network for 2b (Mercury, vers. 1.1). Figure 2 . XSHELL plot of 3a (50 % probability level).
which led to the formation of the desired products in good yields. The compounds were characterized by the standard spectroscopic and spectrometric methods. In the case of the glycine ethyl ester derivative 3a, colorless single crystals were grown from dichloromethane/hexane at room temperature. 3a crystallizes in the monoclinic space group P2 1 / c. The molecular structure is shown in Figure 2 . Bond lengths and angles are in the expected range ( Single crystals grew from a methanolic solution by slow evaporation of the solvent. The compound crystallizes in the monoclinic space group P2 1 /c with two independent molecules in the asymmetric unit. The magnesium cation is octahedrally coordinated by six water ligands. The molecular structure is depicted in Figure 3 , bonding parameters are contained in Table 2 . There are hydrogen bonds between the waters of crystallization O8 and O9 (2.74 Å), O8 and the pyridine-N (2.83 Å), and O9 and water coordinated to Mg 2+ (2.79 Å). Following a procedure described previously, [8] the vanadium(IV) complexes 4a-b were isolated from the reaction of vanadyl sulfate and the acids 2a-b as green microcrystalline powders. Green single crystals of compound 4a·0.5H 2 O were obtained from a hot aqueous solution on slow cooling. The compound crystallizes in the monoclinic space group www.eurjic.orgP1 with two independent molecules and one water of (7), O2-V1-N2 164.62 (7), O7-V1-N1 161.62(6)°.
crystallization, disordered over two positions, in the asymmetric unit. Two ligands coordinate in the expected bidentate manner to form, together with an aqua ligand (O2) in the equatorial plane and an oxo ligand (O1) in the apical position, a distorted octahedron, Figure 4 . The oxygen O3 of one of the carboxylato groups occupies the axial position trans to the oxo ligand, leading to the rather long V1-O3 distance 2.1290(15) Å due to the trans influence of the doubly bonded oxygen. The isopropyl group of one of the ligands is disordered over two positions (1:1) in one of the two independent molecules. The bonding parameters for the coordinated ligand anion are the same within the error limits as in the free ligand 2a ( Table 1 ). The water of crystallization is in hydrogen-bonding contact with the carboxylate oxygens O4 (2.79 Å) and O3 (2.83 Å). For the synthesis of the vanadium(IV) complexes 4c-d and 5a-d, an aqueous solution of vanadylsulfate was mixed with a solution of the proligand and sodium acetate in THF/water and heated to reflux for 6 h. Under these conditions, the deprotection of the 2-position of the ligand precursor and the subsequent formation of the desired vanadium complex took place. The resulting dark green solution was evaporated to dryness. Recrystallization from THF yielded complexes 4c-d and 5a-d as green solids. All analyses confirmed the coordination of two ligand molecules to the metal center plus a solvent molecule, commonly water; cf. Scheme 1 and 4a in Figure 4 .
Insulin-Mimetic Tests
The biological tests with regard to glucose uptake and metabolism were carried out with a modified (see below) MTT reduction assay using Simian virus transformed mice fibroblasts as described earlier. [16] In this assay, yellow soluble MTT is reduced to insoluble formazan blue by reduction equivalents generated by the metabolism of glucose by the mitochondrial respiratory chain. The amount of formazan blue is determined photometrically and correlates with the ability of either insulin or the vanadium compound to stimulate cellular glucose uptake and metabolism by the cells. The cells were grown to sub-confluency, and incubated in insulin-free medium for 24 h in order to minimize effects other than those imparted by the vanadium compound. This procedure was followed by 3 h incubation with the medium supplemented with the vanadium compound. This modified MTT test has previously been verified using -[C6-
3 H]glucose. [16] In order to determine the time dependent effect, a sample was taken every 15-30 minutes. Compounds included in this study are 4c, 5a, 5c, 5d, VOSO 4 , and [VO(5MeOdipic) 2 ], the insulin-mimetic activity of which has been established earlier, and which proved most effective among the alkyl derivatives [VO(5ROdipic) 2 ]. [8] The amino acid derivative with alanine, 5b, displayed a behavior similar to the glycine derivative 5a. Figure 5 shows the absorbance for different concentrations of the vanadium compounds relative to a control group (without vanadium or insulin), and cells incubated with insulin instead of the vanadium compound. The data after 60 minutes incubation time are shown. During this time, about 90 % of the overall effect is observed (see below). Except for the glycine derivative 5a, all compounds exhibit insulin-mimetic properties in the concentration range (1 µ Յ c Յ 200 µ) tested. The most promising results are those for the phenylalanine derivative 5d, showing comparable stimulation of glucose uptake and metabolism as insulin. Particularly noteworthy is the fact that even at rather low concentrations (c Ͻ 10 µ) the vanadium complexes are still active ( Figure 5 ).
The time-dependent effect of compounds 4c and 5a, [VO-(5MeOdipic) 2 time dependence in activity for the compounds apparently is not as significant as one might expect when considering the differences in the ligand spheres. Further, Figure 6 clearly shows that the galactose derivative 4c exhibits, at this specific concentration, an insulin-mimetic activity comparable to the well established efficiency of [VO(pic) 2 ] [5] and [VO(5MeOdipic) 2 ]. [8] The time dependent insulin-mimetic effect of 4c at different concentrations reveals that the maximum level of activity at high concentrations (c = 400 µ and 200 µ) is already reached after an incubation time of approx. 45 minutes, cf. Figure 7 . In this respect, 4c is unique, since all of the other compounds considered in this study displayed the highest activity after 60 to 90 minutes, even at high concentrations (not shown). Furthermore, the effect promoted by 4c at c = 400 µ and 200 µ is significantly higher than the activity of insulin itself. 
Conclusions
In extension of earlier work, [8] we have introduced here a new concept for the design of potentially insulin-mimetic vanadium(IV) compounds. The framework represented by pyridine-2,5-dicarboxylic acid was extended by introducing, into the 5-position, organic molecules into the ligand sphere for which membrane receptors exist and/or which modify the hydro/lipophilicity of the dipicolinatovanadium com-plexes. Here, we have employed amino acids, galactose and inositol residues, along with alkyl derivatives for comparison. Selected compounds were subjected to in vitro studies of their ability to stimulate glucose uptake and oxidative degradation by modified fibroblasts on the one hand, and to inhibit lipolysis by adipocytes on the other hand. Except for the glycine and -alanine derivatives, all compounds were effective insulin-mimetics in the glucose uptake experiments in the concentration range 200 to 1 µ. The galactose containing complex initiated an earlier saturation of glucose uptake in the time-dependent studies than other compounds, which can be interpreted in terms of a faster uptake of the galactosyl complex by the cells. All of the complexes also showed insulin-mimetic activity in the inhibition of li-polysis, in particular at relatively high concentrations of 1 m.
Experimental Section
General and Chemicals: All preparations of vanadium complexes in the oxidation state +IV were carried out under nitrogen atmosphere, using Schlenk techniques. For further handling of the complexes, Schlenk techniques were dispensable. Chemicals were obtained from Merck, Aldrich and Fluka and used without further purification unless stated otherwise. Solvents were dried and purified by standard procedures. Tetrahydrofuran (THF) was dried and deoxygenated by refluxing for at least three hours over LiAlH 4 and distilled in an N 2 stream. Triethylamine was distilled (88-90°C) and stored over molecular sieves (4 Å). Dichloromethane was refluxed for 24 h over calcium hydride. Toluene was refluxed for 24 h over sodium and then distilled in an N 2 stream. Pyridine (H 2 O Յ 0.005 %) was stored over molecular sieve. Deionized water was degassed before use. Products were dried at room temperature under vacuum and stored under N 2 . The following compounds were prepared according to published procedures: 6-(methoxycarbonyl)-pyridine-3-carboxylic acid (1), [9] methyl 5-(chlorocarbonyl)pyridine-2-carboxylate, [10] myo-inositol-orthoformate, [11, 12] 1,2:3,4-di-O-isopropylidene-α--galactose, [13] [VO(pic) 2 ], [14] K[VO 2 (pic) 2 ], [14] K[VO 2 (2,5dipic)]. [15] Analyses and Methods: Elemental analyses were carried out in the Analytical Laboratory of the Chemistry Department, University of Hamburg. Infrared spectra were recorded as KBr pellets on a Perkin-Elmer 1720 FT-IR spectrometer. NMR spectra were obtained either on a Varian Gemini 200 BB or a Bruker Avance 400 spectrometer at room temperature in 5 mm tubes. Chemical shifts δ are reported in ppm (parts per million) relative to TMS for 1 H and 13 C NMR spectra. Coupling constants (J) are quoted in Hertz. Mass spectrometry was carried out at the Institute of Organic Chemistry, University of Hamburg, with the usual spectrometer settings on a Varian MAT 311A (70 eV, EI) or a VG Analytical 70-250 S (FAB). EPR spectra of 4a-d and 5a-d were scanned at ca. 9.6 GHz (Xband) on a Bruker ESP-300 E spectrometer at room temperature and 100 K. Parameter adaptations by simulation were achieved by using the Bruker software SimFonia. X-ray structure analyses were carried out at 153(2) K using Mo-K α irradiation (λ = 0.71073 Å, graphite monochromator) on a Smart Apex CCD diffractometer. Hydrogen atoms were usually found, and otherwise calculated into idealized positions and included in the last cycles of refinement. Absorption corrections were carried out by SADABS. Structure solution and refinement were carried out using the SHELXTLPlus software package (G. M. Sheldrick, Version 5.1, Bruker AXS, 1998). For crystal data and structure refinement see Table 2 .
CCDC-22102, -285853, -225187, and -257605 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
Insulin-Mimetic Tests:
Tests for the glucose uptake activity were based on the MTT (MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) reduction assay. [16] The cells were cultured in glucose-rich DMEM medium (Dulbecco's modification of Eagle's medium) supplemented with 10 % fetal calf serum at 37°C/5 % CO 2 to subconfluency. Afterwards, the cells were passed to an insulin-free, DMEM high glucose medium for 24 h. For the MTT tests, DMEM (without phenol red) supplemented with MTT (Sigma; 0.5 g/L) and solutions of the vanadium complexes in dif-ferent concentrations were added to the cells and incubated for up to 3 h at 37°C in a 5% CO 2 atmosphere. The cells were separated from the medium and the reaction was stopped by addition of 0.1  HCl in 2-propanol. The insoluble dye was extracted by HCl/2-propanol, and the amount of formazan blue formed by reduction of MTT was measured at 570 nm in a multi-well reader (SLT 340 ATC). All measurements were carried out in triplicate; standard deviations for the absorbances typically amount to 4 ± 2 %.
Tests for the inhibition of free fatty acid (FFA) release were performed on epidymal fat pads, excised from male Wistar rats (7 weeks) anesthetized with diethyl ether. The pads were cut into appropriately sized pieces and were incubated with collagenase in KRB buffer (Krebs-Ringer hydrogen carbonate buffer; 120 m NaCl, 1.27 m CaCl 2 , 1.2 m MgSO 4 , 4.75 m KCl, 1.2 m KH 2 PO 4 , and 24 m NaHCO 3 ; pH 7.4) containing 2 % BSA at 37°C with gentle shaking at 100 cycle/min for 1 h. At the end of the incubation period, the prepared cells were filtered through sterilized cotton gauze and washed three times with the KRB buffer. The cells were incubated at 37°C for 30 min with the vanadium complexes, dissolved in DMSO, at various concentrations (0.1-1.0 m), including 1 m ascorbic acid to prevent their oxidations in KRB buffer containing 2 % DMSO. A 10 µ solution of epinephrine was then added to the reaction mixtures, and the resulting solutions were incubated at 37°C for 3 h. The mixtures were centrifuged at 3000 rpm for 10 min at 4°C. On the outer solution of the cells, the FFA level was determined with a FFA kit (NEFA C test; Wako, Osaka, Japan).
All animal experiments in the present study were approved by the Experimental Animal Research Committee of Kyoto Pharmaceutical University (KPU), and were performed according to the Guideline for Animal Experimentation of the KPU.
Synthesis and Characterization
For the NMR assignments, the numbering of the ring-H and -C atoms follows the usual one. C1 and C7 refer to the carboxylic carbons in the ring positions 2 and 5, respectively. 
General Procedure for the Syntheses of the Ligands 2a-b:
To a solution of methyl 5-(chlorocarbonyl)pyridine-2-carboxylate (1.5 g, 7.56 mmol) in toluene (5 mL) was added dropwise and with cooling a 1.4 fold excess of the alcohol in pyridine (15 mL). After the addition of a catalytic amount of 4-(dimethylamino)pyridine, the resulting dark solution was stirred overnight at room temperature. The solvent was evaporated and the residue dissolved in water. The aqueous solution was extracted with dichloromethane (5 × 30 mL). The organic layer was dried with Na 2 SO 4 and the solvent evaporated. Purification was carried out using column chromatography on silica gel, elutant ethyl acetate/n-hexane, 1:1, to give a light yellow solid (yield 59-65 %) which was treated with an equimolar amount of Cu(NO 3 ) 2 ·3H 2 O, followed by treatment with hydrogen sulfide as has been described earlier [8] to produce the ligands as white solids in yields of 50-85 %. 
5-(Isopropyloxycarbonyl
Preparation of the Galactose/Inositol Derivatives 2c, 2d:
To a solution of methyl 5-(chlorocarbonyl)pyridine-2-carboxylate (600 mg, 3.0 mmol) in toluene (10 mL) in an ice bath was added a solution of the corresponding alcohol (3.0 mmol) in pyridine (15 mL). After addition of a catalytic amount of 4-(dimethylamino)pyridine, the resulting solution was stirred for 12 h at room temperature. The solvent was evaporated and the residue extracted with toluene (10 mL), followed by dichloromethane (10 mL). The galactose derivative was dissolved in 1-butanol and the organic phase washed with water and a diluted solution of Na 2 CO 3 . The organic layer was dried with MgSO 4 and the solvent was evaporated to yield a yellow oil. The inositol derivative was dissolved in water and the aqueous phase was extracted with ethyl acetate. The organic layer was dried with MgSO 4 and the solvent was evaporated to yield a light yellow solid. (27) , 1 H, H-4 (10) [ 
